# OnCo record allotera-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/allotera-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "allotera-therapeutics" ;
  schema:name "Allotera Therapeutics (formerly Wugen)"@en ;
  schema:description "Allotera, formerly Wugen, makes off-the-shelf CAR T-cell therapies from healthy donor cells for T-cell leukaemias and lymphomas, which are hard to treat with conventional CAR T because the cancer cells look like the therapy cells. Its lead product is in a global pivotal trial."@en ;
  schema:url <https://onco.cc/companies/allotera-therapeutics/>, <https://alloteratx.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://alloteratx.com/>, <https://alloteratx.com/allotera-therapeutics-formerly-wugen-closes-35-million-financing-to-advance-off-the-shelf-car-t-therapies-for-t-cell-cancers/> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/aml/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/allogeneic-cell-therapy/>, <https://onco.cc/technologies/car-t/> ;
  onco:trials <https://onco.cc/trials/nct06514794/> .